Engaged Capital

Engaged Capital

13F Holdings and Portfolio Analysis

Glenn W. Welling 2018 Q4 13F holdings, quarterly changes, portfolio value trend and position weight distribution.

Engaged Capital Overview

Engaged Capital held 15 stocks in 2018 Q4, with total market value around $0.54B.

Engaged Capital's top five holdings in 2018 Q4: HAIN CELESTIAL GROUP INC(HAIN) 34.59%, UPBOUND GROUP INC(UPBD) 16.01%, APOGEE ENTERPRISES INC(APOG) 9.35%, BENCHMARK ELECTRONICS INC(BHE) 8.78%, SUNOPTA INC COMMON STOCK(STKL) 4.92%.

Portfolio Value
$0.54B
Current Holdings
15 stocks
New / Increased
2 / 3
Reduced / Exited
6 / 3

Current Holdings

1HAIN CELESTIAL GROUP INCHAIN0.1934.59%11.76 -$15.86- $38.210.002.00-$0.26B-58.49%Held
2UPBOUND GROUP INCUPBD0.0916.01%5.33 +17.65%$16.19- $4.82+0.802.25+$0.06B+235.96%Increased
3APOGEE ENTERPRISES INCAPOG0.059.35%1.69 +13.30%$29.85- $43.70+0.201.25-$0.02B-31.70%Increased
4BENCHMARK ELECTRONICS INCBHE0.058.78%2.24 -1.41%$21.18- $24.86-0.034.00-$0.01B-14.79%Reduced
5SUNOPTA INC COMMON STOCKSTKL0.034.92%6.86 -$3.87- $7.050.002.75-$0.02B-45.13%Held
6NCR VOYIX CORPVYX0.024.61%1.08 -0.24%$23.08- $30.06-0.001.50-$0.01B-23.22%Reduced
7DEL FRISCOS RESTAURANT GROUPCUSIP 2450771020.024.41%3.33 $7.15- $7.15+3.330.25$0.00B0.00%New
8TIVO CORP COMCUSIP 88870P1060.024.41%2.52 -$9.41- $19.520.002.50-$0.03B-51.80%Held
9ARATANA THERAPEUTICS INC COMCUSIP 03874P1010.023.96%3.49 -14.22%$6.13- $4.98-0.581.00+$0.00B+23.09%Reduced
10MAGELLAN HEALTH INCCUSIP 5590792070.012.70%0.26 $56.89- $56.89+0.260.25$0.00B0.00%New
11ANIKA THERAPEUTICS INCANIK0.012.34%0.37 -3.10%$33.61- $35.27-0.010.75-$0.00B-4.72%Reduced
12INNERWORKINGS INC COMCUSIP 45773Y1050.011.79%2.58 +51.49%$3.74- $5.26+0.880.50-$0.00B-28.96%Increased
13GROUPON INC COMCUSIP 3994731070.011.45%2.45 -2.80%$3.20- $1.43-0.070.75+$0.00B+123.24%Reduced
14ASTEC INDS INCCUSIP 0462241010.000.41%0.07 -$30.19- $50.400.000.50-$0.00B-40.11%Held
15BABCOCK & WILCOX ENTERPRIS I COMCUSIP 05614L1000.000.27%3.77 -16.24%$0.39- $3.31-0.731.25-$0.01B-88.20%Reduced
Showing 1-15 of 15

"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.

Cost basis is an estimate and can differ materially from the actual cost, especially in edge cases.

Cost basis estimate: from the latest uninterrupted holding period, new or increased shares are added to the cost pool at the report price; reductions remove shares at the then-average cost. Example: buy 100 shares at $10 in Q1 and add 50 shares at $16 in Q2, estimated cost basis is (100 x 10 + 50 x 16) / 150 = $12 per share.

Return shows estimated dollar return on top and percentage return below. It uses current price when available, otherwise report price.

Exited Holdings

Stocks no longer disclosed in the current 13F portfolio for 2018 Q4.

1CELESTICA INC SUB VTG SHSCUSIP 15101Q1081.441.25$10.85$10.83-$0.00B-0.22%
2UNIVERSAL ELECTRONICS INCUEIC0.190.50$33.05$39.35+$0.00B+19.06%
3PUMA BIOTECHNOLOGY INCCUSIP 74587V1070.150.25$45.85$45.85$0.00B0.00%
Showing 1-3 of 3

Exited holdings are stocks disclosed in the previous report period but no longer disclosed in the current 13F portfolio.

"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.

Cost basis uses the same weighted cost-pool method as current holdings. Estimated exit price uses the current report period weighted report price when available, otherwise the previous report price; it does not represent the actual sale price.

Exit return shows estimated dollar return on top and percentage return below.

Portfolio Visuals

Track portfolio value, position weights and Top 10 history.

Market Value Trend ($B)

50 periods

Position Weight

TOP10

Holding Changes ($B)

All-period Top 10

Top 10 Holdings Replay

Animated view